The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In recent years, people have turned to weight loss jabs instead to help them lose weight after they were approved for use by UK and US health bodies.

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, Wegovy, Mounjaro and Zepbound, a clinical trial shows.